https://www.scmp.com/rss/510701/feed Emily Edwards is a research fellow, Allergy and Clinical Immunology Laboratory, Monash University in Australia. She has a PhD from Cardiff University. Her work currently focuses on investigating the impact of genetic mutations on B cell differentiation and function in patients with primary immunodeficiencies. en https://assets.i-scmp.com/static/img/icons/scmp-meta-1200x630.png https://www.scmp.com A number of countries including the United States and the United Kingdom are moving to make a third dose of a Covid-19 vaccine available to people who are immunocompromised. But why are people with weaker immune systems at the front of the queue for a third dose? As the global Covid-19 vaccine roll-out continues, emerging data is showing those who are immunocompromised are not necessarily as well protected by the first two doses. So for these people, a third dose, sooner rather than later, could... https://www.scmp.com/week-asia/explained/article/3147200/coronavirus-why-third-vaccine-shot-important-people-who-are?utm_source=rss_feed https://www.scmp.com/week-asia/explained/article/3147200/coronavirus-why-third-vaccine-shot-important-people-who-are?utm_source=rss_feed Thu, 02 Sep 2021 00:00:32 +0000